Drug Profile
RPH 120
Alternative Names: RPH-120Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator R-Pharm
- Developer TR-Pharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in Turkey
- 05 Jul 2016 Early research in Cancer in Turkey (unspecified route)